Literature DB >> 35674945

Susceptibility Testing of Candida auris Isolates.

Elizabeth M Johnson1,2, Andrew M Borman3,4.   

Abstract

Susceptibility testing of isolates of Candida auris is helpful as a guide to the selection of the most appropriate antifungal agent for treatment as different clades and strains within clades often demonstrate markedly different susceptibility profiles. Some strains are relatively susceptible to all antifungal drugs, but most demonstrate innate resistance to fluconazole, many are cross-resistant to other azoles and others demonstrate resistance to other classes of antifungal. The finding of multi-drug resistance, where an isolate is resistant to two or more classes of antifungal agent, is not uncommon, and development of resistance during a course of treatment has also been documented. This chapter describes a reference broth microdilution method for susceptibility testing and a commercially available gradient strip method.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Candida auris; MIC; Resistance; Susceptibility testing

Mesh:

Substances:

Year:  2022        PMID: 35674945     DOI: 10.1007/978-1-0716-2417-3_5

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  7 in total

1.  MIC distributions for amphotericin B, fluconazole, itraconazole, voriconazole, flucytosine and anidulafungin and 35 uncommon pathogenic yeast species from the UK determined using the CLSI broth microdilution method.

Authors:  Andrew M Borman; Julian Muller; Jo Walsh-Quantick; Adrien Szekely; Zoe Patterson; Michael D Palmer; Mark Fraser; Elizabeth M Johnson
Journal:  J Antimicrob Chemother       Date:  2020-05-01       Impact factor: 5.790

2.  Molecular Epidemiology of Candida auris in Colombia Reveals a Highly Related, Countrywide Colonization With Regional Patterns in Amphotericin B Resistance.

Authors:  Patricia Escandón; Nancy A Chow; Diego H Caceres; Lalitha Gade; Elizabeth L Berkow; Paige Armstrong; Sandra Rivera; Elizabeth Misas; Carolina Duarte; Heather Moulton-Meissner; Rory M Welsh; Claudia Parra; Luz Angela Pescador; Nohora Villalobos; Soraya Salcedo; Indira Berrio; Carmen Varón; Andrés Espinosa-Bode; Shawn R Lockhart; Brendan R Jackson; Anastasia P Litvintseva; Mauricio Beltran; Tom M Chiller
Journal:  Clin Infect Dis       Date:  2019-01-01       Impact factor: 9.079

3.  Comparison of EUCAST and CLSI Reference Microdilution MICs of Eight Antifungal Compounds for Candida auris and Associated Tentative Epidemiological Cutoff Values.

Authors:  M C Arendrup; Anupam Prakash; Joseph Meletiadis; Cheshta Sharma; Anuradha Chowdhary
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

4.  Candida auris Isolates of the Southern Asian and South African Lineages Exhibit Different Phenotypic and Antifungal Susceptibility Profiles In Vitro.

Authors:  Adrien Szekely; Andrew M Borman; Elizabeth M Johnson
Journal:  J Clin Microbiol       Date:  2019-04-26       Impact factor: 5.948

5.  Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris.

Authors:  Milena Kordalewska; Annie Lee; Steven Park; Indira Berrio; Anuradha Chowdhary; Yanan Zhao; David S Perlin
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

6.  Genomic epidemiology of the UK outbreak of the emerging human fungal pathogen Candida auris.

Authors:  Johanna Rhodes; Alireza Abdolrasouli; Rhys A Farrer; Christina A Cuomo; David M Aanensen; Darius Armstrong-James; Matthew C Fisher; Silke Schelenz
Journal:  Emerg Microbes Infect       Date:  2018-03-29       Impact factor: 7.163

Review 7.  Review on Antifungal Resistance Mechanisms in the Emerging Pathogen Candida auris.

Authors:  Farid Chaabane; Artan Graf; Léonard Jequier; Alix T Coste
Journal:  Front Microbiol       Date:  2019-11-29       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.